Evaluation of mucoadhesive carrier adjuvant: Toward an oral anthrax vaccine

References

• Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. 1993. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci USA. 90:2291.
   PubMed Web of Science ®Google Scholar
• Berthold I, Pombo ML, Wagner L, Arciniega JL. 2005. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminium adjuvants. Vaccine. 23:1993–1999.
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, Caramella C. 1999. A modified cell for simultaneous assessment of drug release and washability of mucoadhesive gels. Pharm Dev Technol. 4:45–53.
   PubMed Web of Science ®Google Scholar
• Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger HE. 2005. Preparation of coated microparticles for a new mucosal vaccine delivery system. Int J Pharm. 299:155–166.
   PubMed Web of Science ®Google Scholar
• Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR. 2003. Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen. J Immunol. 170:5636–5643.
   PubMed Web of Science ®Google Scholar
• Debin A, Kravtzoff R, Santiago JV, Cazales L, Sperandio S, Melber K, et al. 2002. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine. 20: 2752–2763.
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Rice TR. 1990. Controlled vaccine release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches. J Control Release. 11:205–214.
   Web of Science ®Google Scholar
• Elson CO, Ealding W, Lefkowitz JA. 1984. Lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretions. J Immunol Methods. 67:101–108.
   PubMed Web of Science ®Google Scholar
• Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM. 2001. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine. 19:3241.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Rodriguez ML, Holgado MA, Sanchez-Lafuente C, Rabasco AM, Fini A. 2002. Alginate/chitosan particulate systems for sodium diclofenac release. Int J Pharm. 232:225–234.
   PubMed Web of Science ®Google Scholar
• Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. 2001. Quantitative pathology of inhalational anthrax. I. Quantitative microscopic findings. Mod Pathol. 14:482.
   PubMed Web of Science ®Google Scholar
• He P, Davis SS, Illum L. 1998. In-vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm. 166: 75–88.
   Web of Science ®Google Scholar
• Ivins BE, Pitt ML, Fellows PF, Farchaus JW, Benner GE, Waag DW, et al. 1998. Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques. Vaccine. 16:1141.
   PubMed Web of Science ®Google Scholar
• Jaganathan KS, Rao YUV, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP. 2005. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm. 294:23–32.
   PubMed Web of Science ®Google Scholar
• Jain S, Sharma RK, Vyas SP. 2006. Chitosan microparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization. J Pharm Pharmacol. 58: 303–310.
   PubMed Web of Science ®Google Scholar
• Jain S, Singh P, Mishra V, Vyas SP. 2005. Mannosylated niosomes as adjuvant-carrier system for oral genetic immunization against hepatitis B. Immunol Lett. 101:41–49.
   PubMed Web of Science ®Google Scholar
• Lopez CR, Portero A, Lemos M, Vila-Jato JL, Nunez MJ, Riveiro P, et al. 2000. Chitosan microspheres for the specific delivery of amoxycillin to the gastric cavity. STP Pharma Sci. 10:69–76.
   Google Scholar
• Malik B, Goyal AK, Mangal S, Zakir F, Vyas SP. 2010. Implication of gut immunology in the design of oral vaccines. Curr Mol Med. 10: 47–70.
   PubMed Web of Science ®Google Scholar
• Mangal S, Pawar D, Garg NK, Jain AK, Vyas SP, Rao DS, Jaganathan KS. 2011. Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally. Vaccine. 29:4953–4962.
   PubMed Web of Science ®Google Scholar
• Medina E, Guzmán CA. 2000. Modulation of immune responses following antigen administration by mucosal route. FEMS Immunol Med Microbiol. 4:305–311.
   Google Scholar
• Mishra N, Goyal AK, Tiwari S, Paliwal R, Paliwal SR, Vaidya B, et al. 2010. Recent advances in mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymeric carriers. Expert Opin Ther Pat. 20:661–679.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 5:55–63.
   Google Scholar
• Pawar D, Goyal AK, Mangal S, Mishra N, Vaidya B, Tiwari S, et al. 2010. Evaluation of mucoadhesive PLGA microparticles for nasal immunization. AAPS J. 12:130–137.
   PubMed Web of Science ®Google Scholar
• Reuveny S, White MD, Adar YY, Altboum YKZ, Gozes Y, Kobiler D, et al. 2001. Search for correlates of protective immunity conferred by anthrax vaccine. Infect Immun. 69:2888–2893.
   PubMed Web of Science ®Google Scholar
• Rossi S, Bonferoni MC, Ferrari F, Caramella C. 1999. Drug release and washability of mucoadhesive gels based on sodium carboxymethylcellulose and polyacrylic acid. Pharm Dev Technol. 4:55–63.
   PubMed Web of Science ®Google Scholar
• Shimoda J, Onishi H, Machida Y. 2001. Bioadhesive characteristics of chitosan microspheres to the mucosa of rat small intestine. Drug Dev Ind Pharm. 27:567–576.
   PubMed Web of Science ®Google Scholar
• Singh Y, Leppla SH, Bhatnagar R, Friedlander AM. 1989. Internalization and processing of Bacillus anthracis lethal toxin by toxin- sensitive and resistant cells. J Biol Chem. 64:11099–11102.
   Google Scholar
• Smith MW, Thomas NW, Jenkins NW, Miller PG, Cremaschi NGA, Porta C. 1995. Selective transport of microparticles across peyer's follicle associated M cells from mice and rats. Exp Phys. 80: 735–743.
   PubMed Web of Science ®Google Scholar
• Welkos S, Friedlander A, Weeks S, Little S, Mendelson I. 2002. In-vitro characterization of the phagocytosis and fate of anthrax spores in macrophages and the effects of anti-PA antibody. J Med Microbiol. 51:821.
   PubMed Web of Science ®Google Scholar
• Welkos S, Little S, Friedlander A, Fritz D, Fellows P. 2001. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores. Microbiology. 147:1677.
   PubMedGoogle Scholar
• Williamson ED, Beedham RJ, Bennett AM, Perkins SD, Miller J, Baillie LWJ. 1999. Presentation of protective antigen to the mouse immune system: immune sequelae. J Appl Microbiol. 87:315–317.
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. 2003. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 250: 215–226.
   PubMed Web of Science ®Google Scholar